18F FDG PET-CT Super scan: Paediatric Rhabdomyosarcoma

Area of Science:

• Pediatric Oncology
• Radiology
• Medical Imaging

Background:

• Rhabdomyosarcoma (RMS) is the most frequent pediatric soft-tissue sarcoma, accounting for 50% of cases.
• RMS is a complex malignancy with potential origins in various body tissues, excluding bone.
• Four main subtypes exist: embryonal, botryoidal, alveolar, and pleomorphic.

Purpose of the Study:

• To highlight the critical role of [18F]-FDG PET-CT in the management of rhabdomyosarcoma.
• To emphasize the importance of accurate staging for high-risk pediatric rhabdomyosarcoma.
• To underscore the need for timely intervention in rhabdomyosarcoma progression.

Main Methods:

• Utilizing [18F]-FDG PET-CT for staging, response evaluation, and follow-up of rhabdomyosarcoma.
• Assessing tumor localization, local infiltration, nodal involvement, and distant metastases for staging.
• Integrating imaging findings with clinical data for comprehensive disease assessment.

Main Results:

• [18F]-FDG PET-CT is vital for determining the extent of rhabdomyosarcoma, including primary tumor characteristics and metastatic spread.
• Accurate staging, informed by PET-CT, is paramount due to the significant morbidity and mortality associated with high-risk disease.
• The staging process integrates tumor location, local invasion, lymph node status, and visceral metastases.

Conclusions:

• [18F]-FDG PET-CT is indispensable for comprehensive rhabdomyosarcoma staging and management.
• Timely and accurate staging is critical for optimizing treatment strategies and improving outcomes in pediatric rhabdomyosarcoma.
• Prompt intervention is essential, as rhabdomyosarcoma can progress rapidly.